Fralex Therapeutics Inc. , a medical technology company developing neuromodulation therapy, today announced the initiation of RELIEF, its pivotal study for the treatment of chronic pain associated with fibromyalgia.
From: biz.yahoo.com
Thursday, March 22, 2007
Fralex Therapeutics Inc. initiates pivotal trial for chronic pain associated with fibromyalgia
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vtZsDjnIofTCqmpG-s6NP_uaDzNmbL-wKalHScxz2i455pyMjdPSxFfNHxqhKY5--c4tB3rvP1oxgSHDfvI47G4G0fsA=s0-d)
![PingOmatic AutoDiscovery [Enabled]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uG4e8Q9tqC5oBv0N86AU33HSsN5uDoXyFi3RtzMm2rg9s_s5L9NzLqyT1Kj6pUebuoucAHyzGoxKsqtFoGwsQcOOPXIYK5njmkI4cwDsCONvTvCFfkGnAObLdtYkSi=s0-d)
![Made with Palestinian Efforts [True]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uPTCbnGVfV2FZKEGvN_t2MM0kie6hZVos6buAcxve-4dgAQRw09lwlwzqmVrQTBbs9ac1piXmw2WSuQnO2jUo3_OBVzJ9x3UC5X-jCGdY4xtMefNCABBmRrg=s0-d)
No comments:
Post a Comment